<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740685</url>
  </required_header>
  <id_info>
    <org_study_id>CHCPWDTM</org_study_id>
    <nct_id>NCT03740685</nct_id>
  </id_info>
  <brief_title>Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis</brief_title>
  <official_title>Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      changes in high sensitive C reactive protien with different treatment modalities in acute
      pancreatitis
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 9, 2018</start_date>
  <completion_date type="Anticipated">October 8, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 9, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>High sesitive C reactive protien</measure>
    <time_frame>72hours</time_frame>
    <description>Level of High sesitive C reactive protien expected to be changed with different lines of treatment and will be compaered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Amylase</measure>
    <time_frame>72hours</time_frame>
    <description>Level of Serum Amylase expected to be changed with different lines of treatment and will be compaered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Lipase</measure>
    <time_frame>72hours</time_frame>
    <description>Level of Serum Lipase expected to be changed with different lines of treatment and will be compaered</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pancreatitis, Acute</condition>
  <arm_group>
    <arm_group_label>Patients with acute pancreatitis</arm_group_label>
    <description>All patients will recive different lines of treatment {saline,antibiotics,dexamethasone}</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>High sesitive C reactive protien</intervention_name>
    <description>High sesitive C reactive protien will be evaluated at admission time and after 36 hours</description>
    <arm_group_label>Patients with acute pancreatitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute pancreatitis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;=18 years

          -  Diagnosis of acute pancreatitis confirmed by at least 2 of the following:

               1. Typical epigastric abdominal pain

               2. Elevation amylase/lipase &gt;3 times upper limit normal and/or

               3. Confirmatory findings on cross-sectional imaging

               4. Enrollment within 8 hours of presentation

        Exclusion Criteria:

          -  Class II or greater NYHA heart failure

          -  Oxygen dependent COPD

          -  Chronic kidney disease&gt;stage 2

          -  Existing necrosis on abdominal CT

          -  Organ dysfunction prior to enrollment

          -  Sepsis

          -  Acute respiratory distress syndrome

          -  Malignancy not in remission for at least 5 years

          -  Active drug use

          -  Known allergy to dexamethasone

          -  Altered mental status

          -  Insulin-requiring diabetes

          -  Abdominal surgery within 60days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mahmoud Abd Elhamed, principal participant</last_name>
    <phone>01017141345</phone>
    <email>mahmoudsisi100@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assuit</city>
        <zip>171516</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>October 11, 2018</study_first_submitted>
  <study_first_submitted_qc>November 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>November 9, 2018</last_update_submitted>
  <last_update_submitted_qc>November 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mahmoud Abdelhamed</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

